GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: QL-1604 | QL1604
iparomlimab is an approved drug
Compound class:
Antibody
Comment: Iparomlimab (QL1604) is a humanized monoclonal antibody against programmed cell death protein 1 (PD-1). It blocks the inhibitory PD-1/PD-L1/2 immune checkpoint.
|
Classification ![]() |
|
| Compound class | Antibody |
| Approved drug? | Yes. China NMPA (2024) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 11840 | iparomlimab |
Synonyms ![]() |
| QL-1604 | QL1604 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 1203 |
| Other databases | |
| GtoPdb PubChem SID | 507750425 |
| Search PubMed clinical trials | iparomlimab |
| Search PubMed titles | iparomlimab |
| Search PubMed titles/abstracts | iparomlimab |